This is VAERS ID 308192
| Days after submission:||11
|Vaccination / Manufacturer
||Lot / Dose
||Site / Route|
|HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC.
||- / UNK
||UN / UN
Administered by: Other Purchased by: Other
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Other Medications: Unknown
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0708USA01229
Write-up: Information has been received from a physician concerning an approximately 13 year old female who "a few years ago" in approximately 2004 was vaccinated with a dose of RECOMBIVAX HB. Subsequently the patient fainted after vaccination. No further information was provided. The patient''s outcome was not reported. Additional information is not expected. The patient had a similar experience after vaccination with GARDASIL (MSD) (WAES # 0706USA05225).
Link To This Search Result:
2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166